Steward Partners Investment Advisory, LLC Crispr Therapeutics Ag Transaction History

Steward Partners Investment Advisory, LLC

$16.6 Billion
Q3 2025

A detailed history of Steward Partners Investment Advisory, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 2,761 shares of CRSP stock, worth $152,738. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,761

Previous 1,992 38.6%

Holding current value

$152,738

Previous $96,000 85.42%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$48.51 - $68.14 $37,304 - $52,399	769 Added 38.6%	2,761 $178,000
Q2 2025 Aug 12, 2025	BUY	$31.27 - $48.64 $17,261 - $26,849	552 Added 38.33%	1,992 $96,000
Q1 2025 May 13, 2025	BUY	$34.03 - $53.02 $19,703 - $30,698	579 Added 67.25%	1,440 $49,000
Q4 2024 Feb 06, 2025	SELL	$38.65 - $55.15 $3,362 - $4,798	-87 Reduced 9.18%	861 $33,000
Q3 2024 Nov 14, 2024	SELL	$44.62 - $62.75 $8,522 - $11,985	-191 Reduced 16.77%	948 $44,000

Q2 2024 Aug 08, 2024	SELL	$51.17 - $68.18 $20,621 - $27,476	-403 Reduced 26.13%	1,139 $61,000
Q1 2024 May 15, 2024	SELL	$60.67 - $89.12 $27,908 - $40,995	-460 Reduced 22.98%	1,542 $105,000
Q4 2023 Feb 12, 2024	BUY	$38.62 - $72.18 $695 - $1,299	18 Added 0.91%	2,002 $125,000
Q3 2023 Nov 13, 2023	BUY	$45.39 - $59.0 $1,407 - $1,829	31 Added 1.59%	1,984 $90,000
Q2 2023 Aug 14, 2023	SELL	$43.47 - $67.77 $1,521 - $2,371	-35 Reduced 1.76%	1,953 $109,000
Q1 2023 May 15, 2023	SELL	$41.0 - $56.12 $820 - $1,122	-20 Reduced 1.0%	1,988 $89,000
Q4 2022 Feb 15, 2023	BUY	$39.19 - $65.67 $3,723 - $6,238	95 Added 4.97%	2,008 $81,000
Q3 2022 Nov 10, 2022	SELL	$61.1 - $83.78 $1,894 - $2,597	-31 Reduced 1.59%	1,913 $125,000
Q2 2022 Aug 04, 2022	BUY	$43.23 - $73.83 $6,398 - $10,926	148 Added 8.24%	1,944 $118,000
Q1 2022 May 02, 2022	BUY	$53.19 - $79.24 $58,136 - $86,609	1,093 Added 155.48%	1,796 $113,000
Q4 2021 Feb 08, 2022	SELL	$70.09 - $111.29 $24,391 - $38,728	-348 Reduced 33.11%	703 $53,000
Q3 2021 Nov 12, 2021	SELL	$110.2 - $156.64 $79,233 - $112,624	-719 Reduced 40.62%	1,051 $118,000
Q2 2021 Aug 13, 2021	SELL	$100.84 - $161.89 $240,402 - $385,945	-2,384 Reduced 57.39%	1,770 $287,000
Q1 2021 May 14, 2021	BUY	$110.72 - $210.04 $358,400 - $679,899	3,237 Added 353.0%	4,154 $506,000
Q4 2020 Feb 11, 2021	BUY	$79.67 - $173.23 $43,340 - $94,237	544 Added 145.84%	917 $140,000
Q3 2020 Oct 30, 2020	BUY	$78.5 - $100.64 $5,730 - $7,346	73 Added 24.33%	373 $31,000
Q2 2019 Jul 25, 2019	BUY	$35.45 - $48.2 $10,635 - $14,460	300 New	300 $14,000
Q4 2018 Jan 15, 2019	SELL	$22.73 - $42.34 $6,819 - $12,702	-300 Closed	0 $0
Q3 2018 Oct 23, 2018	BUY	$44.35 - $65.71 $8,870 - $13,141	200 Added 200.0%	300 $13,000
Q1 2018 Apr 20, 2018	BUY	$23.52 - $58.17 $2,352 - $5,817	100 New	100 $4,000

Others Institutions Holding CRSP

# of Institutions

543

Shares Held

67.4M

Call Options Held

3.5M

Put Options Held

3.08M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.32B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.

Account

Steward Partners Investment Advisory, LLC Crispr Therapeutics Ag Transaction History